Vital Pharmaceuticals, Inc. Bankruptcy Docket

Cases

Plan effective Nov 21, 2023

Updated Oct 20, 8:48 AM ET

Petition filed
Oct 10, 2022
Plan confirmed
Nov 8, 2023

Vital Pharmaceuticals is in post-confirmation liquidation, with the VPX Liquidating Trust pursuing recoveries and seeking to extend its dissolution date to November 21, 2029, through its October 9, 2026 motion Dkt. 3096. The next scheduled milestones are an October 29 partial-summary-judgment hearing Dkt. 647 and a November 10 hearing on the extension request Dkt. 3097.

Motion10:00 AM ETDkt. 623Order Setting Deadlines And Hearing On (Re: [556] Motion for Summary Judgment filed by Plaintiff VPX Liquidating Trust). Hearing scheduled for 10/29/2026 at 10:00 AM C. Clyde Atkins U.S. Courthouse, 301 N Miami Ave Courtroom 8, Miami, FL 33128. (Rodriguez, Olga)

in 7 days

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

Berger Singerman LLPBankruptcy Counsel
Lowenstein Sandler LLPBankruptcy Counsel
Grant Thornton LLPFinancial Advisor
Lincoln Partners Advisors LLCFinancial Advisor
Rothschild & Co US Inc.Investment Banker

Recent activity

Vital Pharmaceuticals: Trust dissolution extension hearing scheduled
Oct 15, 2026
· p. 1 Dkt. 3097 · pp. 2, 4, 5, 9, 10 Dkt. 3096

Recent filings

Oct 19Order Granting Seal MotionBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 657Dkt. 657
Oct 15Hearing on Dissolution ExtensionBankr. S.D. Fla., No. 22-17842, ECF No. 3097View on PACERDkt. 3097
Oct 13Motion to Seal ExhibitsBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 656Dkt. 656
Oct 12Trust Replies to Additional FactsBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 655Dkt. 655
Oct 12Trust Reply on Additional FactsBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 654Dkt. 654
Oct 12Trust’s Partial Judgment ReplyBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 653Dkt. 653

Full docket (5,168) →

Case facts and filing dates come from court records.

Plan effective Nov 21, 2023

Updated Oct 20, 8:48 AM ET

Petition filed
Oct 10, 2022
Plan confirmed
Nov 8, 2023

in 7 days

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

Berger Singerman LLPBankruptcy Counsel
Lowenstein Sandler LLPBankruptcy Counsel
Grant Thornton LLPFinancial Advisor
Lincoln Partners Advisors LLCFinancial Advisor
Rothschild & Co US Inc.Investment Banker

Recent activity

Vital Pharmaceuticals: Trust dissolution extension hearing scheduled
Oct 15, 2026
· p. 1 Dkt. 3097 · pp. 2, 4, 5, 9, 10 Dkt. 3096

Recent filings

Oct 19Order Granting Seal MotionBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 657Dkt. 657
Oct 15Hearing on Dissolution ExtensionBankr. S.D. Fla., No. 22-17842, ECF No. 3097View on PACERDkt. 3097
Oct 13Motion to Seal ExhibitsBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 656Dkt. 656
Oct 12Trust Replies to Additional FactsBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 655Dkt. 655
Oct 12Trust Reply on Additional FactsBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 654Dkt. 654
Oct 12Trust’s Partial Judgment ReplyBankr. S.D. Fla., Adv. No. 24-01009, ECF No. 653Dkt. 653

Full docket (5,168) →

Case facts and filing dates come from court records.

Vital Pharmaceuticals, Inc.

Plan effective Nov 21, 2023

Research this case

Key firms

Recent activity

Vital Pharmaceuticals: Trust dissolution extension hearing scheduled

Recent filings

Plan effective Nov 21, 2023

Research this case

Key firms

Recent activity

Vital Pharmaceuticals: Trust dissolution extension hearing scheduled

Recent filings

Vital Pharmaceuticals, Inc.

Vital Pharmaceuticals, Inc.

Vital Pharmaceuticals, Inc.

Plan effective Nov 21, 2023

Research this case

Key firms

Recent activity

Vital Pharmaceuticals: Trust dissolution extension hearing scheduled

Recent filings